Saxon scientists want to find more effective ways of treating the deadly disease with the help of immunotherapy and artificial intelligence

A team of scientists from the Fraunhofer Institute for Cell Therapy and Immunology IZI, the University of Leipzig, and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has begun a research project focused on improving skin cancer treatment. Set to run for three years, the goal of the KI-CARs project is to use artificial intelligence (AI) to activate the body’s own immune system to fight malignant tumors more effectively and with fewer side effects.

Immunotherapy is one treatment method for cancer, but it is associated with side effects and can’t help all patients. So the KI-CARs project will be centered on a new variant of CAR-T cell immuno-therapy, with the hope of expanding therapeutic options for skin cancer patients in the future. Researchers in Leipzig will be using modern gene sequencing methods to gather complex data sets, which will be analyzed using AI. AI will also help in making any potential new treatment options as effective and safe as possible.

Learn more at idw-online.de